In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
15 weeks 19 hours ago
19 weeks 1 day ago
20 weeks 5 days ago
20 weeks 6 days ago
33 weeks 1 day ago
38 weeks 6 days ago
49 weeks 6 days ago
50 weeks 6 days ago
1 year 2 days ago
1 year 5 days ago